Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.72x is 24% above its 3-year average of -3.56x, near the high end of its 3-year range (-12.34x–-2.23x).
As of the fiscal period ended Sunday, June 30, 2024. 3.73% above its 12-month average of -2.82x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2024 (2024-06-30): -2.72x.
INTEREST COVERAGE RATIO
-2.72x
INTEREST COVERAGE RATIO AVG TTM
-2.82x
INTEREST COVERAGE RATIO AVG 3Y
-3.38x
INTEREST COVERAGE RATIO AVG 5Y
-3.56x
INTEREST COVERAGE RATIO AVG 10Y
-21.11x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.73%
CURRENT VS 3Y AVG
+19.63%
CURRENT VS 5Y AVG
+23.82%
CURRENT VS 10Y AVG
+87.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+57.41%
vs the sector median at left
Minerva Neurosciences, Inc.
Market Cap
$159.80M
Interest Coverage Ratio
-2.72x
TTM Avg
-2.82x
3Y Avg
-3.38x
5Y Avg
-3.56x
Market Cap
$159.14M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$162.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$156.22M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
Market Cap
$165.32M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
Market Cap
$153.79M
Interest Coverage Ratio
-3.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $159.80M | -2.72x | -2.82x | -3.38x | -3.56x |
| PepGen Inc. (PEPG)vs › | $159.78M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -5.64x | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | -19.95x | 6.75x | 6.75x | 6.75x |
| Quanterix Corporation (QTRX)vs › | $162.04M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | N/A | 2247.41x | 1131.54x | 905.57x |
| Nkarta, Inc. (NKTX)vs › | $165.27M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 2.28x | 2.28x | 2.28x | 2.28x |
| Neuronetics, Inc. (STIM)vs › | $153.79M | -3.74x | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | -1.03x | N/A | N/A | N/A |
Interest Coverage
-2.7x
Debt/Equity
N/A
Current Ratio
20.14
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-06-30 | -2.72x |
| 2024-03-31 | -2.97x |
| 2023-12-31 | -3.27x |
| 2023-09-30 | -2.92x |
| 2023-06-30 | -2.23x |
| 2023-03-31 | -2.70x |
| 2022-12-31 | -2.63x |
| 2022-09-30 | -2.78x |
| 2022-06-30 | -3.81x |
| 2022-03-31 | -4.49x |
| 2021-12-31 | -12.34x |
| 2021-09-30 | -4.46x |
| 2021-06-30 | -5.56x |
| 2021-03-31 | -5.79x |
| 2018-09-30 | -3092.09x |
| 2018-06-30 | -361.50x |
| 2018-03-31 | -180.38x |
| 2017-12-31 | -91.01x |
| 2017-09-30 | -82.72x |
| 2017-06-30 | -57.29x |
| 2017-03-31 | -52.03x |
| 2016-12-31 | -39.75x |
| 2016-09-30 | -31.81x |
| 2016-06-30 | -18.51x |
| 2016-03-31 | -28.69x |
| 2015-12-31 | -29.62x |
| 2015-09-30 | -21.13x |
| 2015-06-30 | -22.96x |
| 2015-03-31 | -25.48x |
| 2014-09-30 | -1830.20x |
| 2014-06-30 | -10.23x |
| 2014-03-31 | -8.48x |
| 2013-12-31 | -34.26x |
| 2013-09-30 | -170.08x |
